ISRCTN13698207Active, not recruitingPhase 1
A randomised pilot study to assess the safety and feasibility of adding a Cytosorb filter during kidney normothermic machine perfusion.
niversity of Cambridge0 sites20 target enrollmentStarted: February 6, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Patients receiving a kidney from donation after brain death (DBD) and/or donation after circulatory death (DCD) donor =50 years
- •2. Transplant recipients aged =18 years
- •3. Patients undergoing a 1st or 2nd kidney transplant
- •4. Patients who have given written informed consent
- •5. Patients that are receiving renal replacement therapy
Exclusion Criteria
- •1. Patient receiving a kidney from DCD and DBD donor <50 years old
- •2. Patients receiving a 3rd or subsequent kidney transplant
- •3. Patients receiving multi-organ transplants e.g. simultaneous pancreas-kidney transplantation
- •4. Patients receiving dual kidney transplants
- •5. Paediatric en-bloc kidney transplants
- •6. Patients that are pre-dialysis
- •7. Kidneys will complex vascular anatomy
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A study to assess the combination of Famotidine and Celecoxib in patients COVID-19CTRI/2022/09/045626Sir Hurkisondas Nurrotumdas Reliance Foundation Hospital and Research Centre
Active, not recruiting
Not Applicable
Study to prove the safety and efficacy of platelet rich plasma tenotomy for the treatment of chronic epicondylitisEUCTR2013-000478-32-ESJose Ignacio Martin Gomez
Not yet recruiting
Phase 2
Clinical study of nutritional supplement Supply6 360 to improve gut health.CTRI/2024/03/063507Kanari Nutrition Pvt. Ltd.
Completed
Not Applicable
A randomised, open study to assess the safety and efficacy of a new artesunate-mefloquine coformulation with an equivalent dose regimen of the individual drugs for the treatment of acute uncomplicated falciparum malaria (Thailand)Infections and InfestationsMalariaISRCTN10364429Drugs for Neglected Diseases initiative (DNDi) (Switzerland)500
Active, not recruiting
Phase 1
A prospective randomized pilot trial on safety and feasibility of Argatroban as blood thinner in patients with heart-lung machinepatients requiring treatment with extracorporeal membrane oxygenationEUCTR2021-001456-34-ATMedical University of Vienna40